Published in BMC Cancer on September 18, 2017
Participation in cancer clinical trials: race-, sex-, and age-based disparities. JAMA (2004) 14.05
External validity of randomised controlled trials: "to whom do the results of this trial apply?". Lancet (2005) 11.35
What influences recruitment to randomised controlled trials? A review of trials funded by two UK funding agencies. Trials (2006) 7.32
How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to cancer treatment trials. J Clin Oncol (2002) 4.68
Systematic review of barriers to the recruitment of older patients with cancer onto clinical trials. J Clin Oncol (2005) 3.34
Reasons for accepting or declining to participate in randomized clinical trials for cancer therapy. Br J Cancer (2000) 3.12
Characteristics of oncology clinical trials: insights from a systematic analysis of ClinicalTrials.gov. JAMA Intern Med (2013) 2.86
Agreement between self-reported breast cancer treatment and medical records in a population-based Breast Cancer Family Registry. J Clin Oncol (2005) 2.70
Recruitment and participation in clinical trials: socio-demographic, rural/urban, and health care access predictors. Cancer Detect Prev (2006) 2.48
Participation in surgical oncology clinical trials: gender-, race/ethnicity-, and age-based disparities. Ann Surg Oncol (2007) 2.46
Evaluation of factors affecting awareness of and willingness to participate in cancer clinical trials. J Clin Oncol (2005) 2.10
Barriers and facilitators to enrollment in cancer clinical trials: qualitative study of the perspectives of clinical research associates. Cancer (2002) 2.05
Factors that predict the referral of breast cancer patients onto clinical trials by their surgeons and medical oncologists. J Clin Oncol (2000) 1.94
Factors affecting patient enrollment in radiology clinical trials: a case study of the American College of Radiology Imaging Network. Acad Radiol (2002) 1.70
Never too old? Age should not be a barrier to enrollment in cancer clinical trials. Oncologist (2005) 1.58
Patient income level and cancer clinical trial participation. J Clin Oncol (2013) 1.48
Barriers to clinical trial participation as perceived by oncologists and patients. J Natl Compr Canc Netw (2007) 1.43
Participation of the elderly population in clinical trials: barriers and solutions. Cancer Control (2014) 1.09
Strategies addressing barriers to clinical trial enrollment of underrepresented populations: a systematic review. Contemp Clin Trials (2014) 1.08
Nurse Practitioners' attitudes about cancer clinical trials and willingness to recommend research participation. Contemp Clin Trials (2011) 0.95
Clinical trial discussion, referral, and recruitment: physician, patient, and system factors. Cancer Causes Control (2013) 0.89
Clinical trial awareness: Changes over time and sociodemographic disparities. Clin Trials (2015) 0.84
Enrollment of patients to clinical trials in haematological cancer in New South Wales: current status, perceived barriers and opportunities for improvement. Intern Med J (2009) 0.82
Evaluation of patient enrollment in oncology phase I clinical trials. Oncologist (2013) 0.81
Barriers to recruitment in cancer trials: no longer medical oncologists' attitudes. Med J Aust (2012) 0.81
Timely completion of scientifically rigorous cancer clinical trials: an unfulfilled priority. J Clin Oncol (2013) 0.80
Understanding decision and enabling factors influencing clinical trial participation in Australia: a view point. Asian Pac J Cancer Prev (2011) 0.77
Effect of medical oncologists' attitudes on accrual to clinical trials in a community setting. J Oncol Pract (2013) 0.77